| Concord Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 538965 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE858L01010 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 33.88 |
Market Cap(₹Cr) : 37.39 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 11.84 | 6.35 | 14.47 | 12.62 | 7.38 | 8.79 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11.84 | 6.35 | 14.47 | 12.62 | 7.38 | 8.79 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Total Income | 11.85 | 6.35 | 14.47 | 12.62 | 7.39 | 8.79 |
| Total Expenditure | 11.05 | 5.62 | 14.28 | 12.06 | 5.85 | 7.39 |
| PBIDT | 0.80 | 0.73 | 0.19 | 0.56 | 1.54 | 1.40 |
| Interest | 0.39 | 0.37 | 0.38 | 0.43 | 0.39 | 0.39 |
| PBDT | 0.41 | 0.36 | -0.19 | 0.13 | 1.15 | 1.01 |
| Depreciation | 0.34 | 0.34 | 0.39 | 0.38 | 0.38 | 0.38 |
| Tax | 0.03 | 0.02 | -0.22 | 0.00 | 0.25 | 0.18 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| Reported Profit After Tax | 0.05 | 0.01 | -0.35 | -0.24 | 0.53 | 0.49 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.05 | 0.01 | -0.35 | -0.24 | 0.53 | 0.49 |
| EPS (Unit Curr.) | 0.05 | 0.01 | -0.35 | -0.24 | 0.56 | 0.52 |
| EPS (Adj) (Unit Curr.) | 0.05 | 0.01 | -0.35 | -0.24 | 0.56 | 0.52 |
| Calculated EPS (Unit Curr.) | 0.05 | 0.01 | -0.35 | -0.24 | 0.56 | 0.52 |
| Calculated EPS (Adj) (Unit Curr.) | 0.05 | 0.01 | -0.35 | -0.24 | 0.56 | 0.52 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.22 | 0.05 | -1.42 | -0.96 | 2.26 | 2.09 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.22 | 0.05 | -1.42 | -0.96 | 2.26 | 2.09 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.00 | 10.00 | 10.00 | 10.00 | 9.32 | 9.32 |
| Reserve & Surplus | 23.88 | 23.83 | 23.82 | 24.17 | 23.83 | 22.88 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.76 | 11.50 | 1.31 | 4.44 | 20.87 | 15.93 |
| PBDTM(%) | 3.46 | 5.67 | -1.31 | 1.03 | 15.58 | 11.49 |
| PATM(%) | 0.42 | 0.16 | -2.42 | -1.90 | 7.18 | 5.57 |